Slate Medicines has secured a $130m Series A financing round aimed at advancing anti-PACAP migraine therapies.

Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.

NorthX Biologics and Demeetra have entered a strategic partnership focused on integrated CLD and GMP manufacturing.

The US Food and Drug Administration (FDA) has issued more information to sponsors regarding its “plausible mechanism pathway”, a new framework to spur the development of therapies for ultra-rare ...

This deal adds two more siRNA candidates to GSK’s pipeline, which is expanding as the company looks to offset the impact of ...

Beren Therapeutics has received the US FDA acceptance to review its NDA for adrabetadex, an investigational therapy targeting intracellular cholesterol trafficking for infantile-onset NPC.

AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

We’re proud to share that EMBOCAPS® has once again been awarded the EcoVadis Gold rating, following last year’s recognition.

Sanofi and Bavarian Nordics are amongst the recipients of eight-year EU vaccine contracts that will help bring new products ...

Three new members could join Novo’s council, which largely consists of recent appointees following a restructure in October ...

AstraZeneca has secured approval in the US for Calquence plus venetoclax as the first all-oral, fixed-duration regimen to treat adults with CLL and SLL in the first-line setting.

The healthcare editorial teams discusses the key trends and growth drivers in companies' recent 2025 financial results.